- Extreme heat another form of death sentence in Texas jails
- Can music help plants grow? Study suggests sound boosts fungus
- Nike earnings drop, says turnaround will take time
- US dockworkers launch mass strike a month before election
- Iron Dome: Israel's key anti-missile shield
- Cranes stand still as US dockworkers fight for 'future'
- GM reports US sales dip, but says EVs grew
- Sheinbaum takes office as Mexico's first woman president
- Webb telescope detects carbon dioxide on Pluto's largest moon
- Stock markets slump, oil jumps on Middle East concerns
- French PM vows more taxes and spending cuts ahead of budget fight
- Germany inaugurates IBM's first European quantum data centre
- Stock markets diverge as eurozone inflation drops further
- France's richest man takes control of Paris Match magazine
- Anger meets tear gas as Nigeria hardship protests fizzle out
- US dockworkers launch mass strike month before election
- Evacuations from Lebanon: what we know
- Feathers fly at Chanel's Paris fashion return
- UAE oil giant ADNOC swoops on German chemicals firm Covestro
- Eurozone inflation falls under 2% for first time since 2021
- Coldplay ticket scalping fiasco sparks backlash in India
- Droughts drive Spanish boom in pistachio farming
- Tokyo recovers some losses to lead Asian markets higher
- Rural schools empty in North Macedonia due to exodus
- US dockworkers launch strike after labor contract expires
- Thousands evacuated as Super Typhoon Krathon approaches Taiwan
- Kenya airport whistleblower fears for his life
- Sheinbaum to take office as Mexico's first woman president
- Scientists fear underfunded Argentina research on verge of collapse
- US port officials gird for strike despite last-minute bargaining
- With 118 dead from Hurricane Helene, Biden defends US government response
- Breeder who tried to create enormous trophy sheep jailed in US
- Qatar Airways seeking 25% stake in Virgin Australia
- US port officials gird for strike as labor talks stay stuck
- As toll crosses 100, Trump puts Hurricane Helene at election center stage
- US Fed Chair sees 'further disinflation' in economy
- Epic Games sues Google and Samsung over app store
- Officials see no shortages from likely US port strike
- UK families of Gaza hostages warn Lebanon attack 'takes focus away'
- Shares in Stellantis, Aston Martin skid on profit warnings
- Dali prints found in London garage sold at auction
- ECB chief backs bank mergers amid UniCredit, Commerzbank talk
- China stocks soar on stimulus, but US and Europe retreat
- 100 dead in storm Helene damage, flooding across US southeast
- China stocks soar on stimulus, Europe slides on automaker woes
- German antitrust watchdog steps up monitoring of Microsoft
- Nepal's urban poor count cost of 'nightmare' floods
- E.Guinea, Gabon clash at ICJ over oil-rich islands
- New blow for UK's Starmer as growth data disappoints
- China's top banks to tweak mortgage rates to boost housing market
Major US baby formula producer agrees with regulators on restarting production
Amid a US shortage of baby formula, officials announced Monday a previously closed manufacturer would re-open and encouraged foreign companies to apply to import their products -- although it will take weeks to see more stock back on store shelves.
A "consent decree" agreement between the Food and Drug Administration (FDA) and major formula manufacturer Abbott outlines steps needed to restart production at the company's plant in Michigan, which was shut down due to a recall, Abbott said in a statement.
"Once the FDA confirms the initial requirements for start-up have been met, Abbott could restart the site within two weeks," the statement said.
However, the company cautioned that "from the time Abbott restarts the site, it will take six to eight weeks before product is available on shelves."
Abbott, which produces the popular Similac brand used by millions of American families, announced a voluntary recall on February 17 after the death of two babies.
In a separate move, the FDA also said Monday it plans to accept applications from international baby formula manufacturers "who don't normally distribute their infant formula products in the US," FDA Commissioner Robert Califf said in a statement.
Currently, the United States produces about 98 percent of the formula it consumes.
- Import applications -
The FDA plans to work to quickly review such applications, especially ones that come from "countries that have health and safety inspection systems similar" to the United States, according to a senior White House official.
The process would also prioritize applications showing "clear quality and safety and nutritional adequacy," a different senior administration official added.
According to Califf, foreign-made baby formula could appear on US shelves within "weeks."
The Biden administration was also reaching out to US manufacturers to offer help with logistical challenges, such as shipping, the officials said.
US families have grown increasingly desperate for formula amid a perfect storm of supply chain issues and the massive recall.
The average out-of-stock rate for baby formula hit 43 percent earlier this month, according to Datasembly, which collected information from more than 11,000 retailers.
Abbott's agreement with the FDA to restart production at the plant in Sturgis, Michigan also needs to be reviewed by a federal court after the Justice Department filed a complaint on Monday.
The complaint says the facility "failed to comply with regulations designed to ensure the quality and safety of infant formula, including protection against the risk of contamination from bacteria."
"The actions we are announcing today will help to safely increase the supply of baby formula for families," US Attorney General Merrick Garland said in a statement.
Robert Ford, chairman and chief executive officer of Abbott said he regretted the situation and that the company already had begun "working to implement improvements and take corrective action."
"We know millions of parents and caregivers depend on us and we're deeply sorry that our voluntary recall worsened the nationwide formula shortage," he said in the statement.
The FDA and White House officials reiterated Monday that parents who are concerned about running out of baby formula should talk to their child's doctor, and that it is not safe to water down existing formula or to make your own at home.
The scarcity is the latest crisis to confound President Joe Biden's push to get the US economy on sound footing amid the highest inflation in four decades and the ongoing global supply chain bottlenecks.
A.Zimmermann--CPN